ADD ANI AS A TRUSTED SOURCE
Add ANI as a Trusted Source for Reliable Information
Menu
Central Drugs Standard Control Organisation extends Covaxin...
New Delhi [India], November 3 (ANI): Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin has received an...
LumiraDx receives approval for its COVID-19 Antigen test for...
London [UK], October 20 (ANI/NewsVoir): Today, LumiraDx, a next-generation point of care diagnostics testing company...
COVID-19: J&J applies for approval to conduct clinical...
New Delhi [India], August 20 (ANI): US pharma giant Johnson & Johnson has moved an application before the...
Expert panel recommends trials on mixing Covaxin and Covishield
New Delhi [India], July 30 (ANI): The Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Zydus Cadila, first Indian Company gets recommendation for...
New Delhi [India], June 4 (ANI): The only Indian company Zydus Cadila which claims to have developed neutralising...
Lilly signs pact with Natco to accelerate availability of...
New Delhi [India], May 17 (ANI): Eli Lilly and Company said on Monday it has issued an additional royalty-free,...
Lilly signs pacts with Cipla, Lupin, Sun Pharma to accelerate...
New Delhi [India], May 10 (ANI): US pharmaceutical major Eli Lilly said on Monday it has issued royalty-free,...
COVID-19: India to decide emergency use authorisation of...
New Delhi [India], March 31 (ANI): Meeting of Subject Expert Committee (SEC) of the Central Drugs Standard...
SEC recommends Dr Reddy's to submit additional data for EUA...
New Delhi [India], February 24 (ANI): The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert...
SEC to discuss Dr Reddy's application for emergency use of...
New Delhi [India], February 24 (ANI): The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert...
DCGI to brief media today on COVID-19 vaccine
New Delhi [India], January 3 (ANI): The Drugs Controller General of India will brief the media at 11 am today at the...
COVID-19: Expert committee recommends restricted emergency...
New Delhi [India], January 2 (ANI): The Subject Expert Committee (SEC) of Central Drugs Standards Control...
Home
About Us
Our Products
Advertise
Contact Us
Terms & Condition
Privacy Policy
Copyright © aninews.in | All Rights Reserved.
Copyright © aninews.in | All Rights Reserved.